Sino-report
Home Sign in Research report Data Center Industry News Custom Research About us
Research report:                          Automotive  |  Electronics  |  Mechanical&Automation  |  New Energy  |  Medical  |  Advanced Materials  |  Building Products  |  Transportation  |  Communication  |  Chemical  |  Finance  |  IT Industry  |  Food  |  Home Appliances  |  Forestry  |  Agriculture  |  Textile  |  Culture Industry  |  Consumer goods  |  Others  |
 Home > Industry News > Medical > Text
China Kanghui Holdings Reports First Quarter 2011 Financial Results
Author:Sino-report    Source:TradersHuddle    Number of clicks :     Update time:2011-05-18 16:18
Sino-report News Center May 2011

CHANGZHOU, China-China Kanghui Holdings (NYSE: KH) ("Kanghui" or the "Company"), a leading domestic developer, manufacturer and marketer of orthopedic implants in China, today announced financial results for the first quarter of 2011.
First Quarter 2011 Highlights
Total net revenue for the first quarter of 2011 increased by 39.3% year-over-year to RMB68.0 million from RMB48.8 million for the first quarter of 2010.
Gross profit for the first quarter of 2011 increased by 40.8% year-over-year to RMB48.7 million from RMB34.6 million for the first quarter of 2010.
Operating income for the first quarter of 2011 increased by 43.3% year-over-year to RMB29.8 million from 20.8 million for the first quarter of 2010.
Net income for the first quarter of 2011 increased by 23.6% year-over-year to RMB22.0 million from RMB17.8 million for the first quarter of 2010.
Non-GAAP1 net income for the first quarter of 2011 increased by 14.1% year-over-year to RMB23.4 million from RMB20.5 million for the first quarter of 2010.
Mr. Libo Yang, the Company's Chief Executive Officer, stated, "We are delighted to report strong financial results for the first quarter of 2011. We experienced significant growth across all product segments and all markets, driven by the solid uptake of our spine products and robust international sales. We continued to implement our strategies, which led to our impressive product growth and further expanded our distribution network, and completed an important acquisition that will help us build our leadership position in China and internationally."
Ms. Sarah Wang, Kanghui’s Chief Financial Officer, said, "Our first quarter performance was primarily driven by strong growth across our business sectors and higher operating leverage through disciplined expense controls. We are off to a good start in 2011. We believe our strategic acquisition of Beijing Wei Rui Li Medical Device Co., Ltd., or "Wei Rui Li", and our partnership with Consensus Orthopedics Inc. will help us further establish Kanghui as a leading international provider of innovative and diversified orthopedic products.”
First Quarter 2011 Financial and Operating Results
Net revenue increased 39.3% to RMB68.0 million ($10.4 million) in the first quarter of 2011 from RMB48.8 million in the first quarter of 2010. Net revenue from trauma products increased 28.8% to RMB42.0 million ($6.4 million) from RMB32.6 million in the corresponding period of the prior year. Net revenue from spine products increased 60.0% to RMB19.2 million ($2.9 million) from RMB12.0 million in the corresponding period of the prior year. Net revenue from OEM products increased 61.9% to RMB6.8 million ($1.0 million) from RMB4.2 million in the corresponding period of the prior year. Domestic sales of proprietary products increased 21.0% year over year to RMB50.1 million ($7.7 million) from RMB41.4 million, while international sales of proprietary products increased 246.9% year over year to RMB11.1 million ($1.7 million) from RMB3.2 million.
In the first quarter of 2011, cost of revenue increased 35.9% to RMB19.3 million ($2.9 million) from RMB14.2 million in the corresponding period of the prior year. Gross profit increased 40.8% to RMB48.7 million ($7.4 million) in the first quarter of 2011 from RMB34.6 million in the corresponding period of the prior year. Gross margin for the first quarter of 2011 was 71.7%, compared to 70.9% in the first quarter of 2010. Selling expenses increased 20.7% to RMB7.0 million ($1.1 million) in the first quarter of 2011 from RMB5.8 million in the corresponding period of the prior year. General and administrative expenses increased 44.4% to RMB10.4 million ($1.6 million) in the first quarter of 2011 from RMB7.2 million in the corresponding period of the prior year. Research and development expenses increased 66.7% to RMB1.5 million ($229,000) in the first quarter of 2011 from RMB0.9 million in the corresponding period of the prior year.
Provision for income taxes in the first quarter of 2011 was RMB9.0 million ($1.4 million), representing an effective tax rate of 29.0%, compared to RMB3.2 million, or an effective tax rate of 15.4%, in the corresponding period of the prior year.
Operating income increased 43.3% to RMB29.8 million ($4.6 million) in the first quarter of 2011 from RMB20.8 million in the corresponding period of the prior year. Operating margin increased to 43.8% in the first quarter of 2011 from 42.7% in the corresponding period of the prior year.
Net income was RMB22.0 million ($3.4 million) in the first quarter of 2011, up 23.6% from RMB17.8 million in the first quarter of 2010. On a diluted per ADS2 basis, the Company reported net income per diluted ADS of RMB0.87 ($0.13) in the first quarter of 2011, compared to a net loss per diluted ADS of RMB0.77 in the corresponding period of the prior year. Non-GAAP net income, which excludes share based compensation expenses, increased 14.1% to RMB23.4 million ($3.6 million) from RMB20.5 million in the corresponding period of the prior year. The Company reported non-GAAP net income per diluted ADS of RMB0.93 ($0.14) in the first quarter of 2011. This compares to a non-GAAP net loss per diluted ADS of RMB0.49 in the corresponding period of the prior year.
During the first quarter of 2011, the Company had a weighted average diluted share count of approximately 150.9 million shares (equivalent to 25.2 million ADSs), compared to 57.7 million shares (equivalent to 9.6 million ADSs), in the first quarter of 2010.
Balance Sheet
As of March 31, 2011, the Company had cash and cash equivalents of RMB177.6 million ($27.1 million), compared to RMB262.5 million as of December 31, 2010. As of March 31, 2011, the Company held short-term investments of RMB261.0 million ($39.9 million), compared to RMB266.7 million as of December 31, 2010.
Business Outlook
Mr. Yang added, "We remain focused on further penetrating both our existing domestic and international markets while expanding into new growth opportunities. As demonstrated by our strong first quarter performance across our business sectors, we are confident in our ability to realize our business plans for the remainder of 2011. We are delighted with the progress achieved, as we position Kanghui as a leader in product quality in the fast-growing and underserved joint reconstruction market in China."
The Company expects year-over-year revenue growth of 20% to 25% in 2011, bringing revenue for the full year 2011 in the range of RMB292 million to RMB303 million. The Company also expects its full year 2011 non-GAAP net income, without taking into account relevant operating expenses in connection with the exclusive partnership with Consensus Orthopedic and the acquisition of the majority stake in Wei Rui Li, to be in the range of RMB128 million to RMB133 million. The impact of the exclusive partnership with Consensus Orthopedic and the acquisition of the majority stake in Wei Rui Li on the Company’s operating expenses is expected to be approximately RMB7 million. After taking into account the operating expenses relating to these transactions, the Company believes that non-GAAP net income for the full year 2011 will be between RMB121 million and RMB126 million.
Non-Cash Share-Based Compensation Expense Discussion
The Company recognized non-cash share-based compensation expenses of approximately RMB1.4 million ($215,000) in the first quarter of 2011.
The Company classified these non-cash share-based compensation expenses in its costs of revenue, selling expenses, general and administrative expenses as well as in research and development expenses. The break out of these expenses per line item is provided in the financial tables attached to this press release.
The Company has provided a non-GAAP presentation of results which excludes the non-cash share based compensation expenses. Please refer to the non-GAAP presentation provided in the appendix for a year over year comparison of non-cash share-based compensation expenses. The Company believes that non-GAAP presentation is a helpful tool for the Company to plan and forecast future periods and both management and investors benefit from referring to such non-GAAP presentation in assessing the performance of the Company.
Conference Call
Kanghui will hold a conference call at 8:00 a.m. ET on May 16, 2011 to discuss results of the first quarter of 2011 and answer questions from investors. A webcast of the call will be available at www.kanghui.com. Listeners may access the call by dialing:
US Toll Free: + 1-800-291-9234
International: + 1-617-614-3923
China Toll Free: 10-800-712-2655
Hong Kong Toll Free: 800-963-844
Passcode: 68017198
A replay of the webcast will be accessible through May 30, 2011 on www.kanghui.com or by dialing:
United States toll free: +1-888-286-8010
International: +1-617-801-6888
Passcode: 97533980
About China Kanghui Holdings
Founded in 1997, Kanghui is a leading domestic developer, manufacturer and marketer of orthopedic implants in China. The Company offers a wide array of proprietary orthopedic implant products in trauma and spine. It has an extensive network of distributors for its products in China. In addition, Kanghui's products are distributed in 27 countries. Kanghui has strong research and development capabilities, focused on developing new proprietary products, including new product lines, extensions of existing product lines and enhancements of existing products. For more information, please visit www.kanghui.com.
 

Order Online
Contact Us
Tel: 400-988-9999
Fax:010-82889999
Phone :+8615313587056
Email:Sale@sino-report.com
Email:Cousult@sino-report.com
Online Consultation
MSN :Sino-report@hotmail.com
MSN :Sino-report@foxmail.com
Skype: Please Please
Latest Reports
  More>>
[Medical] Medical device manufacturers display their latest technology
[Medical] Initiative helps boost traditional Chinese medicine
[Medical] Cancer drug prices set to drop
[Medical] Traditional Chinese medicine exports rebound in 2017
Popular reports
  More>>
Medical device manufacturers display their latest technology
Industry Data
  More>>
China opens market to Kenya's agricultural products
China's publishing industry booming over past 40 years
Industrial Production Operation in July 2018
Total Retail Sales of Consumer Goods in July 2018
National Real Estate Development and Sales in the First Seven Months of 2018
NSDP/SDDS for the People's Republic of China
Market Price of Important Means of Production in Circulation, July 01-10, 2018
In the first five months of 2018, the profits made by industrial enterprises above the designated siz
Purchasing Managers Index for June 2018
Market Price of Important Means of Production in Circulation, June 21-30, 2018
In global EV battery shipments during Jan - Apr 2018, LG Chem and Samsung SDI ranked 4th and 6th
Based on Jan - Apr shipment record, Kia Motors Remain on Top 10 in Global PHEV Power Brands Ranking
Consumer Prices for May 2018
Producer Prices for the Industrial Sector for May 2018
Industrial Production Operation in May 2018
Investment in Fixed Assets for the First Five Months of 2018
National Real Estate Development and Sales in the First Five months of 2018
Producer Prices for the Industrial Sector for April 2018
Stable Performance for the National Economy in April
Total Retail Sales of Consumer Goods in April 2018
Industrial Production Operation in April 2018
National Real Estate Development and Sales in the First four months of 2018
Sales Prices of Residential Buildings in 70 Medium and Large-sized Cities in April 2018
Industrial Profits Increased in the First Four Months of 2018
Industry News
  More>>
Iron and steel sector gains strength
China’s wines take center stage
Machinery manufacturing fair boosts Sino-Russian ties
Medical device manufacturers display their latest technology
Soybean farmers store crops amid hopes of higher prices
Tourism industry opening on agenda
Tech competition eases startups' access to China market
China's excavator sales grow 44.9% in October
China's solid waste imports continue to slump on tightened ban
Delivery orders jump 25.12% to 1.35b on Singles Day
Related Links

Sitemap       |       Join Us      |       Customer Service       |       About Sino-report
Copyright © 2011-2025 Sino-report Consult Inc.
Sino-report@hotmail.com    Postmaster@sino-report.com
No.18 Zhichun Road, Haidian District. Beijing 100089.China
Information and data contained in this site is for reference only pursuant to operate your own risk
Sino-report